Prior work by us and others has also shown that human LAM nodules have elevated expression of PD-L1, an immune checkpoint inhibitor that causes T cell suppression, and LAM causes overexpression of checkpoint molecules PD-1 and CTLA-4 on T cells in a mouse model (17,18). Here, CTLA4 is linked to lymphangioleiomyomatosis.